Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 175Leukemia, Myeloid, Acute 157Myeloproliferative Disorders 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Primary Myelofibrosis 52Leukemia, Myelomonocytic, Chronic 45Lymphoma, Non-Hodgkin 39Leukemia 28Polycythemia Vera 25Hodgkin Disease 25Thrombocythemia, Essential 22Myelodysplastic-Myeloproliferative Diseases 22Multiple Myeloma 21Leukemia, Lymphocytic, Chronic, B-Cell 20Leukemia, Biphenotypic, Acute 19Hematologic Neoplasms 19Neoplasms 17Anemia, Refractory, with Excess of Blasts 15Leukemia, Myeloid, Chronic-Phase 14Sarcoma 13Histiocytosis, Langerhans-Cell 13Glioma 13Recurrence 12Neuroblastoma 12Hematologic Diseases 12Wilms Tumor 11Rhabdoid Tumor 11Osteosarcoma 11Neuroectodermal Tumors, Primitive, Peripheral 11

Interventions

decitabine and cedazuridine drug combination 1avapritinib 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Systemic Mastocytosis With an Associated Hematologic Neoplasm × Myeloid × 90 days × Clear all
NCT06327685 2026-04-01

Avapritinib With Decitabine in Patients With SM-AHN

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
34 enrolled
MyeloidOther hematologic neoplasm

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡